Literature DB >> 9590999

The erythrocyte sedimentation rate. Still a helpful test when used judiciously.

M Brigden1.   

Abstract

ESR is a time-honored, simple, inexpensive test, but unfortunately it lacks sensitivity and specificity. Clinicians need to be aware of appropriate uses, because any test is expensive when ordered often, and evaluation of false-positive results may incur substantial costs and place the patient at risk from additional procedures. ESR should not be used to screen asymptomatic persons for disease. If an increased ESR is encountered and no explanation is immediately apparent, clinicians should repeat the test in several months rather than pursue an exhaustive search for occult disease. ESR may be useful in establishing a "sickness index" in elderly persons who have nonspecific changes in health status and a moderate probability of underlying disease; in screening for infection in specific settings (e.g., orthopedic surgery, pediatrics, gynecology); in diagnosing and monitoring temporal arteritis, polymyalgia rheumatica, and possibly other rheumatic diseases; in monitoring patients with treated Hodgkin's disease; and in assessing iron deficiency in anemia of chronic disease (when correlated with serum ferritin level). An ESR value exceeding 100 mm/hr has a 90% predictive value for serious underlying disease, most often infection, collagen vascular disease, or metastatic tumor. In asymptomatic persons with a markedly elevated ESR value, a minimal number of tests usually reveal the cause.

Entities:  

Mesh:

Year:  1998        PMID: 9590999     DOI: 10.3810/pgm.1998.05.493

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  8 in total

Review 1.  Best practice in primary care pathology: review 2.

Authors:  W S Smellie; J O Forth; C A M McNulty; L Hirschowitz; D Lilic; R Gosling; D Bareford; E Logan; K G Kerr; G P Spickett; J Hoffman; A Galloway; C A Bloxham
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  General or personal diet: the individualized model for diet challenges in patients with rheumatoid arthritis.

Authors:  Saliha Karatay; Teoman Erdem; Ahmet Kiziltunc; Meltem Alkan Melikoglu; Kadir Yildirim; Ebru Cakir; Mahir Ugur; Akin Aktas; Kazim Senel
Journal:  Rheumatol Int       Date:  2005-07-16       Impact factor: 2.631

3.  The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.

Authors:  E Littlejohn; W Marder; E Lewis; S Francis; J Jackish; W J McCune; E C Somers
Journal:  Lupus       Date:  2018-03-16       Impact factor: 2.911

4.  Temporal artery biopsy: impact on the clinical management of patients.

Authors:  M Sintler; A Garnham; A Mahmood; D Rittoo; H S Khaira; R K Vohra
Journal:  Indian J Surg       Date:  2008-05-21       Impact factor: 0.656

5.  The chemistry and toxicity of discharge waters from copper mine tailing impoundment in the valley of the Apuseni Mountains in Romania.

Authors:  Piotr Rzymski; Piotr Klimaszyk; Włodzimierz Marszelewski; Dariusz Borowiak; Mirosław Mleczek; Kamil Nowiński; Bożena Pius; Przemysław Niedzielski; Barbara Poniedziałek
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-25       Impact factor: 4.223

6.  Erythrocyte sedimentation rate in canine leishmaniosis diagnosis: A new resource.

Authors:  Maria Alfonsa Cavalera; Floriana Gernone; Annamaria Uva; Rossella Donghia; Grazia Carelli; Roberta Iatta; Andrea Zatelli
Journal:  Front Vet Sci       Date:  2022-08-01

7.  Contribution of Erythrocyte Sedimentation Rate to Predict Disease Severity and Outcome in COVID-19 Patients.

Authors:  Celali Kurt; Arzu Altunçeki Ç Yildirim
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-08-11       Impact factor: 2.585

8.  Comparison of the erythrocyte sedimentation rate measured by the Micro Test 1 sedimentation analyzer and the conventional Westergren method.

Authors:  Serap Arikan; Nalan Akalin
Journal:  Ann Saudi Med       Date:  2007 Sep-Oct       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.